Abstract
Batteries used for implantable cardiac rhythm devices are described herein. Fully implanted cardiac rhythm devices, pacemakers, and defibrillators treat patients with various cardiomyopathies. Each of these devices contains a battery that supplies all of the energy for device functions. As devices were developed with increased longevity, more features and reduced size, batteries were designed with considerably greater energy and power. New battery concepts resulted in smaller, highly reliable batteries with greater power output and longevity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Webster, J. G. (Ed.). (1995). Design of cardiac pacemakers. New York, IEEE.
Holmes, C. F. (1999). The role of electrochemical power sources in modern health care. The Electrochemical Society Interface, 8(3), 32–34.
The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337(22), 1576–1583.
Moss, A. J., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New England Journal of Medicine, 335(26), 1933–1940.
Moss, A. J., Zareba, W., Hall, W. J., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators, et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346(12), 877–883.
Bristow, M. R., Saxon, L. A., Boehmer, J., et al. (2004). Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350(21), 2140–2150.
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237 Erratum in: New England Journal of Medicine, 352(20), 2146.
Gan, H., et al. (2008) US patent 7,375,496.
Crespi, A. M., Skarstad, P. M. (1995) US patent 5,458,997.
Gan, H., Rubino, R. S., & Takeuchi, E. S. (2005). Dual-chemistry cathode system for high-rate pulse applications. Journal of Power Sources, 146(1–2), 101–106.
Chen, K., Merritt, D. R., Howard, W. G., Schmidt, C. L., & Skarstad, P. M. (2006). Hybrid cathode lithium batteries for implantable medical applications. Journal of Power Sources, 162(2), 837–840.
Gan, H., & Takeuchi, E. S. (2006) US patent 7,108,942.
Crespi, A. M., & Chen, K. (2000) US patent 6,017,656.
O’Phelan, M. J. et al. (2004) US patent application 2004/0127952.
Drews, J., Wolf, R., Fehrmann, G., & Staub, R. (1999). High-rate lithium/manganese dioxide batteries; the double cell concept. Journal of Power Sources, 65(1–2), 129–132.
Ikeda, H., Narukawa, S., Nakashima, H., Fujimoto, M. (1984). In Proceedings volume 84–1, A. N. Dey (Ed.), The Electrochemical Society, 311.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Root, M.J. Implantable Cardiac Rhythm Device Batteries. J. of Cardiovasc. Trans. Res. 1, 254–257 (2008). https://doi.org/10.1007/s12265-008-9054-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-008-9054-9